User profiles for Shevanthi Nayagam

Shevanthi Nayagam

Imperial College London
Verified email at imperial.ac.uk
Cited by 4229

Requirements for global elimination of hepatitis B: a modelling study

S Nayagam, M Thursz, E Sicuri, L Conteh… - The Lancet Infectious …, 2016 - thelancet.com
Background Despite the existence of effective prevention and treatment interventions,
hepatitis B virus (HBV) infection continues to cause nearly 1 million deaths each year. WHO …

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

…, TY Lee, J Malani, TM Morris, S Nayagam… - The lancet …, 2019 - thelancet.com
Viral hepatitis is a major public health threat and a leading cause of death worldwide. Annual
mortality from viral hepatitis is similar to that of other major infectious diseases such as HIV …

The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries

…, D Olivera Mesa, W Green, H Thompson, S Nayagam… - Science, 2020 - science.org
The ongoing coronavirus disease 2019 (COVID-19) pandemic poses a severe threat to public
health worldwide. We combine data on demography, contact patterns, disease severity, …

The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups

N Schmit, S Nayagam, MR Thursz… - International journal of …, 2021 - academic.oup.com
Background Progress towards viral hepatitis elimination goals relies on accurate estimates
of chronic hepatitis B virus (HBV)-infection prevalence. We compared existing sources of …

Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges

M Lemoine, S Nayagam, M Thursz - Future virology, 2013 - Taylor & Francis
Chronic viral hepatitis is a major public health issue worldwide and mostly affects resource-limited
countries. These regions combine a considerable set of barriers to containing the …

Mother‐to‐child transmission of hepatitis B: what more needs to be done to eliminate it around the world?

S Nayagam, Y Shimakawa… - Journal of viral hepatitis, 2020 - Wiley Online Library
Mother‐to‐child transmission (MTCT) of hepatitis B virus (HBV) is a key component of the
hepatitis B burden worldwide. Despite its efficacy to prevent HBV transmission, infant …

The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa

M Lemoine, Y Shimakawa, S Nayagam, M Khalil… - Gut, 2016 - gut.bmj.com
Background Simple and inexpensive non-invasive fibrosis tests are highly needed but have
been poorly studied in sub-Saharan Africa. Methods Using liver histology as a gold standard…

Adapting hospital capacity to meet changing demands during the COVID-19 pandemic

…, JC D'Aeth, A Løchen, D Rizmie, S Nayagam… - BMC medicine, 2020 - Springer
Background To calculate hospital surge capacity, achieved via hospital provision interventions
implemented for the emergency treatment of coronavirus disease 2019 (COVID-19) and …

Global reporting of progress towards elimination of hepatitis B and hepatitis C

…, M Dirac, C de Martel, S Nayagam… - The lancet …, 2023 - thelancet.com
Background The 69th World Health Assembly endorsed the global health sector strategy on
viral hepatitis to eliminate viral hepatitis as a public health threat by 2030. Achieving and …

Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model

A Heffernan, GS Cooke, S Nayagam, M Thursz… - The Lancet, 2019 - thelancet.com
Background The revolution in hepatitis C virus (HCV) treatment through the development of
direct-acting antivirals (DAAs) has generated international interest in the global elimination …